Advisory Board — Medscape Cardiology

Board Members

  • Henry R. Black, MD
    • Clinical Professor of Internal Medicine
      Director of Hypertension Research
      New York University Medical Center
      New York, New York
  • Timothy Gardner, MD
    • Professor, Department of Surgery
      Stanley Kimmel Medical College
      Thomas Jefferson University
      Philadelphia, Pennsylvania
      Medical Director
      Center for Heart and Vascular Health
      Christiana Care Health System
      Newark, Delaware
  • Samuel Z. Goldhaber, MD
    • Professor of Medicine
      Harvard Medical School
      Section Head
      Vascular Medicine
      Director
      Thrombosis Research Group
      Brigham and Women’s Hospital
      Boston, Massachussets
  • Robert Harrington, MD
    • Arthur L. Bloomfield Professor of Medicine
      Chair, Department of Medicine
      Stanford University
      Stanford, California
  • John M. Mandrola, MD
    • Clinical Electrophysiologist
      Baptist Medical Associates
      Louisville, Kentucky
  • Roxana Mehran, MD
    • Professor of Medicine (Cardiology) and Population Health Science and Policy
      Director
      Interventional Cardiovascular Research and Clinical Trials
      Icahn School of Medicine at Mount Sinai
      New York, New York
  • Michelle L. O’Donoghue, MD, MPH
    • TIMI Study Group
      Harvard Medical School
      Brigham and Women’s Hospital
      Boston, Massachusetts
  • Ileana L. Piña, MD, MPH
    • Professor of Medicine
      Department of Cardiology
      Professor of Epidemiology and Population Health
      Associate Chief for Academic Affairs
      Albert Einstein College of Medicine
      Director of Cardiology
      Montefiore Medical Center
      Bronx, New York
  • Melissa Walton-Shirley, MD
    • Clinical Cardiologist
      Cardiology Associates
      Glasgow, Kentucky
  • Howard S. Weintraub, MD
    • Clinical Associate Professor of Medicine and Cardiology
      New York University School of Medicine
      Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
      NYU-Langone Medical Center
      New York, New York
 

Board Member Details

Henry R. Black, MD
Henry R. Black, MD

Adjunct Professor of Medicine, New York University, New York, New York

Henry R. Black, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Zumbro; Pfizer Inc; Hospira
Received income in an amount equal to or greater than $250 from: Zumbro; Pfizer Inc; Hospira

Timothy Gardner, MD
Timothy Gardner, MD

Professor, Department of Surgery, Stanley Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; Medical Director, Center for Heart and Vascular Health, Christiana Care Health System, Newark, Delaware

Timothy Gardner, MD, has disclosed no relevant financial relationships.

Samuel Z. Goldhaber, MD
Samuel Goldhaber, MD

Professor of Medicine, Harvard Medical School; Section Head, Vascular Medicine; Director, Thrombosis Research Group, Brigham and Women’s Hospital, Boston, Massachusetts

Samuel Z. Goldhaber, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Agile Therapeutics Inc.; Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Portola Pharmaceuticals, Inc.; Zafgen
Received research grant from: Bio2 Medical Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; BTG EKOS; Daiichi Sankyo, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Robert Harrington, MD
Robert Harrington, MD

Professor and Chair, Department of Medicine, Stanford University, Stanford, California

Robert A. Harrington, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: HCA Management Services; Medscape; MyoKardia, Inc.; Gilead Sciences, Inc.; The Medicines Company; Intermountain Health; Adverse Events; Amgen Inc; Element Science; Merck & Co., Inc; Vida Health; American Heart Association; Scanadu (mobile health); SignalPath (data)
Received research grants from: National Heart Lung and Blood Institute; Patient-Centered Outcomes Research Institute; Duke University; Harvard University; AstraZeneca Pharmaceuticals LP; CSL Behring; GlaxoSmithKline; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Merck & Co., Inc; Portola Pharmaceuticals, Inc.; Regado Biosciences; sanofi-aventis; The Medicines Company
Received income in an amount equal to or greater than $250 from: HCA Management Services; Medscape; MyoKardia, Inc.; Gilead Sciences, Inc.; The Medicines Company; Intermountain Health; Amgen Inc; Merck & Co., Inc; SignalPath (data)

John M. Mandrola, MD
John M. Mandrola, MD

Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky

John M. Mandrola, MD, has disclosed no relevant financial relationships.

Roxana Mehran, MD
Roxana Mehran, MD

Professor of Medicine (Cardiology) and Population Health Science and Policy, Director, Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai, New York, New York

Roxana Mehran, MD, has disclosed the following financial relationships:
Serve(d) as consultant to: Boston Scientific; Cardiovascular Systems, Inc.; Medscape, LLC; Shanghai BraccoSine Pharmaceutical Corp. Ltd.
Serve(d) on the advisory board for: Bristol-Myers Squibb Company (funding to institution)
Institution received consulting fees from: Abbott Laboratories; American College of Cardiology; CardioKinetix Inc.; Cardiovascular Research Foundation; The Spectranetics Corporation
Serve(d) as a speaker or member of a speakers bureau for: European Society of Cardiology; Gaffney Events Education; International Society for Cardiovascular Translational Research; Life Sciences Conferences; Northwestern University; Prime Healthcare Services; Promedica International CME; The Society of Thoracic Surgeons; University of Utah
Serve(d) on executive committee for: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Osprey Medical
Institution received research funding from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals; Beth Israel Deaconess Medical Center; Bristol-Myers Squibb Company; CSL Behring; Eli Lilly and Company; Daiichi Sankyo, Inc.; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; OrbusNeich
Has <1% equity interest in: Claret Medical, Inc.; Elixir Medical Corporation
Served as a medical monitor for: Claret Medical, Inc. (paid to institution)
Served as a member of the Data and Safety Monitoring Board for: Watermark Research Partners (paid to institution)
Spouse served as a consultant to: ABIOMED; The Medicines Company

Michelle L. O’Donoghue, MD, MPH

Investigator, TIMI Study Group; Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women’s Hospital, Boston, Massachusetts

Michelle L. O'Donoghue, MD, MPH, has disclosed the following relevant financial relationships:
Received research grant from: Merck & Co., Inc.; GlaxoSmithKline; Eisai Inc.; AstraZeneca Pharmaceuticals LP; Janssen Pharmaceuticals

Ileana L. Piña, MD, MPH
Ileana L. Piña, MD, MPH

Professor of Medicine, Department of Cardiology; Professor of Epidemiology and Population Health; Associate Chief for Academic Affairs, Albert Einstein College of Medicine; Director of Cardiology, Montefiore Medical Center, Bronx, New York

Ileana L. Piña, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, office, partner, employee, advisor, consultant, or trustee for: US Food and Drug Administration; Center for Devices and Radiological Health

Melissa Walton-Shirley, MD
Melissa Walton-Shirley, MD

Cardiologist, Cardiology Associates, Glasgow, Kentucky; St. Thomas Heart, Gallatin, Tennessee

Melissa K. Walton-Shirley, MD, has disclosed no relevant financial relationships.

Howard S. Weintraub, MD
Howard S. Weintraub, MD

Clinical Professor of Medicine/Cardiology, New York University School of Medicine; Clinical Director, New York University Center for the Prevention of Cardiovascular Disease, New York University Langone Medical Center, New York, New York

Howard S. Weintraub, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Amgen Inc.; Gilead Sciences, Inc.
Received research grant from: Amarin Corporation plc; sanofi-aventis
Received income in an amount equal to or greater than $250 from: Amgen Inc.; Gilead Sciences, Inc.; Amarin Corporation plc; sanofi-aventis